Up to 48% Off Subscriptions. 30% Off Single Purchases.*
Automatically Applied at Checkout.
Hey Gillian 👋
Exclusive Offer: 30% Off 1st subscription with code NEW30
Exclusive Offer: 30% Off 1st subscription with code NEW30
Translating science into health solutions.
Advancing microbiome-driven solutions to transform immune health, prevent disease, and reach consumers with science-backed innovation.
Stephanie Culler, PhD
CEO & Co-Founder
Steve Van Dien, PhD
CTO & Co-Founder
Founders
Persephone Biosciences was co-founded in 2017 by synthetic biologists Stephanie Culler, Ph.D. and Steve Van Dien, Ph.D., experts in microbiome science and metabolic engineering. From oncology to early-life health, they built Persephone to unlock the therapeutic power of the microbiome and transform how we prevent and treat disease.
Leadership
A cross-functional team with deep expertise in biotech, clinical development, and DTC commercialization, leading innovation from lab to market.
Richard Insel, MD
Chief Medical Advisor
Veronique Riethuisen
Board Member and CBO
Gillian Snyder
Head of Marketing
Shaun Singer
Director of Poop for the Cure®
Bryce Jarman, PhD
Head of Product Development
Pedro Torres, PhD
Head of Computational Biology
Board of Directors
Daniel Bradbury
Chairman, Board of Directors
Paul Grint, MD
Independent Board Member
Veronique Riethuisen
Independent Board Member
Leen Kawas, PhD
Propel Bio Partners
Veronica Breckenridge
First Bight Ventures
Our Research
ARTEMIS – explores
how our synergistic
synbiotic impacts the
microbiome and the gut.
My Baby Biome
The largest and most diverse study ever conducted on infant gut health in the US.
Poop for the cure
Clinical research arm of Persephone Biosciences enabling large scale, data-driven discovery.
Ambrosia
Researching how diet and lifestyle impact your gut microbiome, in partnership with Kroger Health.
Rooted in collaboration with
leaders in science and health
leaders in science and health
Our partners
Our investors
Press
